333
Participants
Start Date
September 19, 2017
Primary Completion Date
January 22, 2019
Study Completion Date
January 22, 2019
Brexpiprazole
Brexpiprazole was administered orally with flexible dosing from 2 to 4 mg/day; titrated to a maximum of 4 mg/day for 3 weeks.
Placebo
Administered orally daily for 3 weeks.
CNS Research Science, Inc., Jamaica
"Communal Establishment Acad. O.I. Iushchenko Vinnytsia Regional Psychoneurologic Hospital", Vinnytsia
New Hope Clinical Research, Charlotte
iResearch Atlanta, LLC, Decatur
Meridien Research, Orlando
Galiz Research, Hialeah
Research Centers of America LLC, Hollywood
Optimus U Corporation, Miami
South Florida Research Phase I-IV, Miami Springs
O.F. Maltsev Poltava Regional Psychiatric Hospital, Poltava
University of Cincinnati Department of Psychiatry and Behavorial Science, Cincinnati
Ternopil Regional Municipal Clinical Psychoneurolgical Hospital, Ternopil
"Communal Institution Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikov", Dnipro
Clinical Hospital Centre Rijeka, Rijeka
Neuropsychiatric Research & Associates, LTD, Winfield
Uptown Research Institute LLC, Chicago
"SI Institute of Neurology, Psychiatry and Narcology of National Academy of Medical Sciences of Ukraine", Kharkiv
Arch Clinical Trials, LLC, St Louis
St Louis Clinical Trials LLC, St Louis
"Communal Establishment Odesa Regional Psychiatric Hospital #2", Oleksandrivka
Louisiana Clinical Research, Shreveport
Atria Clinical Research, Little Rock
Woodland International Research Group, LLC, Little Rock
"Communal Establishment Kherson Regional Psychiatric Hospital of Kherson Regional Council", Kherson
Pillar Clinical Research, LLC, Richardson
InSite Clinical Research LLC, DeSoto
"Communal Institution of Lviv Regional Council Lviv Regional Clinical Psychiatric Hospital, Department #20", Lviv
"Communal Institution of Lviv Regional Council Lviv Regional Clinical Psychiatric Hospital, Department #25", Lviv
Collaborative Neuroscience Network, LLC, Torrance
CNS Research Science Inc., Cerritos
CiTrials, Bellflower
Apostle Clinical Trials, Long Beach
CNRI-San Diego, San Diego
Artemis Institute for Clinical Research, San Diego
CiTrials, Santa Ana
Shreenath Clinical Service, Yorba Linda
Hassman Research Institute, Berlin
"Kyiv Regional Medical Incorporation Psychiatry, Center for Novel Treatment and Rehabilitation of Psychotic disorders", Kyiv
H. Lundbeck A/S
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY